血管支架置入輔助彈簧圈栓塞術(shù)后的顱內(nèi)動脈瘤患者氯吡格雷抵抗影響因素分析
[Abstract]:Objective to investigate the influencing factors of clopidogrel resistance to (CR) in patients with intracranial aneurysms after placement of stent-assisted coil embolization. Methods the clinical data of 132 patients with intracranial aneurysm were collected. All the patients were treated with intracranial stent placement assisted with coil embolization. After operation, aspirin and clopidogrel were used in combination with antiplatelet therapy. Platelet aggregation inhibition rate induced by adenosine diphosphate (ADP) was detected by thromboelastogram coagulation analyzer on the 5th day after operation. The inhibition rate of platelet aggregation induced by ADP was 30% CR.. The patients were divided into CR group and control group according to the existence of postoperative CR. The basic clinical data (age, sex, smoking history, hyperlipidemia history) and clinical biochemical examination results (platelet count, glycosylated hemoglobin, fasting blood glucose) were compared between the two groups. The independent risk factors of clopidogrel resistance to (CR) in patients with intracranial aneurysms were determined by multivariate analysis. Results CR occurred in 36 cases (27.3%, CR group) and clopidogrel sensitive in 96 cases (control group) on the 5th day after operation. The ratio of female composition, platelet count and glycosylated hemoglobin (HbA1c) in the two groups were 0. 05 (P < 0. 05). Smoking, hypertension, hyperlipidemia and fasting blood glucose, triglyceride, and total cholesterol levels, P-all 0.05.Logistic regression analysis showed that women (OR 1.60,95% CI 1.05-3.20), compared with smoking, hypertension, hyperlipidemia and fasting blood glucose, triglyceride and total cholesterol levels. High glycosylated hemoglobin (OR is 2.68,95% CI is 1.10x5.46), The increased platelet count (OR = 2.13, 95% CI: 1.03 鹵4.15) was an independent risk factor for CR after endovascular stent-assisted coil embolization in patients with intracranial aneurysm (P < 0.05). Conclusion female, high glycosylated hemoglobin and increased platelet count are risk factors for CR in patients with intracranial aneurysms after endovascular stent placement assisted coil embolization.
【作者單位】: 濱州市人民醫(yī)院;
【分類號】:R651.12
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 李煒昕;阮法寧;杜天明;陳善成;;微彈簧圈栓塞術(shù)后6天彈環(huán)圈脫出1例[J];實(shí)用醫(yī)學(xué)雜志;2006年17期
2 姜桂芝;;顱內(nèi)動脈瘤彈簧圈栓塞術(shù)的麻醉處理[J];中國冶金工業(yè)醫(yī)學(xué)雜志;2010年02期
3 丁曉麗;王福利;李秀敏;趙永利;楊瑞民;王惠方;;動脈瘤性蛛網(wǎng)膜下腔出血患者行彈簧圈栓塞術(shù)后的生存質(zhì)量分析[J];中華腦科疾病與康復(fù)雜志(電子版);2012年01期
4 唐惟萍;孫忠玲;;顱內(nèi)動脈瘤行彈簧圈栓塞術(shù)39例護(hù)理體會[J];齊魯護(hù)理雜志;2007年10期
5 陳劍紅;孫建紅;方欽偉;;顱內(nèi)動脈瘤彈簧圈栓塞術(shù)患者的術(shù)前護(hù)理[J];護(hù)士進(jìn)修雜志;2008年18期
6 劉美玲;王國芳;李密;;顱內(nèi)動脈瘤彈簧圈栓塞術(shù)后護(hù)理[J];中國醫(yī)療前沿;2012年14期
7 師愛青;;復(fù)方利多卡因乳膏在顱內(nèi)動脈瘤彈簧圈栓塞術(shù)麻醉中的應(yīng)用[J];中國臨床研究;2013年08期
8 姚文英;徐慧琴;;顱內(nèi)動脈瘤彈簧圈栓塞術(shù)的手術(shù)配合[J];護(hù)理與康復(fù);2007年01期
9 蔡靳;吳昌群;;顱內(nèi)動脈瘤血管內(nèi)彈簧圈栓塞術(shù)治療及護(hù)理[J];臨床和實(shí)驗(yàn)醫(yī)學(xué)雜志;2010年12期
10 陳曉青;動脈瘤囊內(nèi)電解可脫性鉑金彈簧圈栓塞術(shù)抗凝的護(hù)理[J];護(hù)理學(xué)雜志;2002年06期
相關(guān)會議論文 前1條
1 張迎春;席剛明;李自然;何玉芳;;顱內(nèi)動脈瘤鉑金微彈簧圈栓塞術(shù)護(hù)理[A];湖北省神經(jīng)科學(xué)學(xué)會學(xué)術(shù)年會論文匯編[C];2007年
相關(guān)碩士學(xué)位論文 前1條
1 趙宇昊;顱內(nèi)動脈瘤可脫落鉑金彈簧圈栓塞術(shù)后隨訪MRA與DSA對比研究[D];吉林大學(xué);2012年
,本文編號:2444419
本文鏈接:http://www.sikaile.net/yixuelunwen/waikelunwen/2444419.html